Filed: 5/15/2023ACC: 0001420506-23-001046
📋 What this filing means
GHOST TREE CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 54 equity positions with a total reported market value of $338.32M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
54
Positions
$338.32M
Total AUM (reported)
16M
Total Shares
Allocation by class
COM$254.39M75.2%
CL A$33.64M9.9%
S&P BIOTECH$22.86M6.8%
SPONSORED ADR$11.79M3.5%
SHS$7.55M2.2%
CLASS A ORD$4.17M1.2%
SPONSORED ADS$2.23M0.7%
Portfolio Concentration
Top 3$82.00M24.2%
4–10$90.95M26.9%
11–25$103.56M30.6%
Rest$61.81M18.3%
Top 3 weight
24.2%
Top 10 weight
51.1%
Voting Authority Distribution
Total shares with voting rights: 16M
Sole
Full voting authority
16M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole54
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings54
Rows:
REATA PHARMACEUTICALS INC
SOLEShares370K
TypeSH
Market value$33.64M
9.94%
Sole
370K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares185K
TypeSH
Market value$25.50M
7.54%
Sole
185K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares300K
TypeSH
Market value$22.86M
6.76%
Sole
300K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares1.10M
TypeSH
Market value$16.54M
4.89%
Sole
1.10M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares216.52K
TypeSH
Market value$14.28M
4.22%
Sole
216.52K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares475K
TypeSH
Market value$13.94M
4.12%
Sole
475K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares225K
TypeSH
Market value$13.88M
4.10%
Sole
225K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares110K
TypeSH
Market value$11.79M
3.49%
Sole
110K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares275K
TypeSH
Market value$10.52M
3.11%
Sole
275K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares600K
TypeSH
Market value$9.99M
2.95%
Sole
600K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares225K
TypeSH
Market value$8.43M
2.49%
Sole
225K
Shared
0.00
None
0.00
CTI BIOPHARMA CORP
SOLEShares2M
TypeSH
Market value$8.40M
2.48%
Sole
2M
Shared
0.00
None
0.00
PFIZER INC
SOLEShares200K
TypeSH
Market value$8.16M
2.41%
Sole
200K
Shared
0.00
None
0.00
REVANCE THERAPEUTICS INC
SOLEShares250K
TypeSH
Market value$8.05M
2.38%
Sole
250K
Shared
0.00
None
0.00
JOHNSON & JOHNSON
SOLEShares50K
TypeSH
Market value$7.75M
2.29%
Sole
50K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares375K
TypeSH
Market value$7.55M
2.23%
Sole
375K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares30K
TypeSH
Market value$7.27M
2.15%
Sole
30K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares200K
TypeSH
Market value$7.16M
2.12%
Sole
200K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares325K
TypeSH
Market value$6.86M
2.03%
Sole
325K
Shared
0.00
None
0.00
IOVANCE BIOTHERAPEUTICS INC
SOLEShares1M
TypeSH
Market value$6.11M
1.81%
Sole
1M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares450K
TypeSH
Market value$5.99M
1.77%
Sole
450K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares550K
TypeSH
Market value$5.93M
1.75%
Sole
550K
Shared
0.00
None
0.00
INCYTE CORP
SOLEShares75K
TypeSH
Market value$5.42M
1.60%
Sole
75K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares475K
TypeSH
Market value$5.27M
1.56%
Sole
475K
Shared
0.00
None
0.00
MIRATI THERAPEUTICS INC
SOLEShares140K
TypeSH
Market value$5.21M
1.54%
Sole
140K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REATA PHARMACEUTICALS INCSOLE | CL A | 370K | SH | $33.64M 9.94% | 370K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 185K | SH | $25.50M 7.54% | 185K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 300K | SH | $22.86M 6.76% | 300K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 1.10M | SH | $16.54M 4.89% | 1.10M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 216.52K | SH | $14.28M 4.22% | 216.52K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 475K | SH | $13.94M 4.12% | 475K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 225K | SH | $13.88M 4.10% | 225K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 110K | SH | $11.79M 3.49% | 110K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 275K | SH | $10.52M 3.11% | 275K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 600K | SH | $9.99M 2.95% | 600K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 225K | SH | $8.43M 2.49% | 225K | 0.00 | 0.00 |
CTI BIOPHARMA CORPSOLE | COM | 2M | SH | $8.40M 2.48% | 2M | 0.00 | 0.00 |
PFIZER INCSOLE | COM | 200K | SH | $8.16M 2.41% | 200K | 0.00 | 0.00 |
REVANCE THERAPEUTICS INCSOLE | COM | 250K | SH | $8.05M 2.38% | 250K | 0.00 | 0.00 |
JOHNSON & JOHNSONSOLE | COM | 50K | SH | $7.75M 2.29% | 50K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 375K | SH | $7.55M 2.23% | 375K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 30K | SH | $7.27M 2.15% | 30K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 200K | SH | $7.16M 2.12% | 200K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 325K | SH | $6.86M 2.03% | 325K | 0.00 | 0.00 |
IOVANCE BIOTHERAPEUTICS INCSOLE | COM | 1M | SH | $6.11M 1.81% | 1M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 450K | SH | $5.99M 1.77% | 450K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 550K | SH | $5.93M 1.75% | 550K | 0.00 | 0.00 |
INCYTE CORPSOLE | COM | 75K | SH | $5.42M 1.60% | 75K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 475K | SH | $5.27M 1.56% | 475K | 0.00 | 0.00 |
MIRATI THERAPEUTICS INCSOLE | COM | 140K | SH | $5.21M 1.54% | 140K | 0.00 | 0.00 |
Page 1 of 3